From: Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer
Low risk
High risk
Risk factors, n
0–1
2–3
Patients, n (%)
25 (61.0Â %)
16 (39.0Â %)
Alb, <3.9Â g/dL, n (%)
6 (14.6Â %)
14 (34.1Â %)
BSI, >1Â %, n (%)
9 (22.0Â %)
Liver mets, yes, n (%)
1 (2.4Â %)
5 (12.2Â %)